[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Moonlake Immunotherapeutics (MLTX)

Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,378,073
  • Shares Outstanding, K 73,615
  • Annual Sales, $ 0 K
  • Annual Income, $ -227,320 K
  • EBIT $ -267 M
  • EBITDA $ -265 M
  • 60-Month Beta 1.04
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.19

Options Overview Details

View History
  • Implied Volatility 90.84% (+5.02%)
  • Historical Volatility 58.98%
  • IV Percentile 48%
  • IV Rank 23.94%
  • IV High 238.49% on 09/17/25
  • IV Low 44.37% on 06/30/25
  • Expected Move (DTE 13) 0.85 (4.75%)
  • Put/Call Vol Ratio 0.14
  • Today's Volume 404
  • Volume Avg (30-Day) 946
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 29,592
  • Open Int (30-Day) 32,621
  • Expected Range 17.05 to 18.75

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.93
  • Number of Estimates 5
  • High Estimate $-0.81
  • Low Estimate $-1.00
  • Prior Year $-0.87
  • Growth Rate Est. (year over year) -6.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.76 +13.58%
on 05/19/26
21.00 -14.76%
on 05/11/26
+0.89 (+5.23%)
since 05/05/26
3-Month
15.76 +13.58%
on 05/19/26
21.00 -14.76%
on 05/11/26
-0.12 (-0.67%)
since 03/05/26
52-Week
5.95 +200.84%
on 09/29/25
62.75 -71.47%
on 09/26/25
-30.93 (-63.34%)
since 06/05/25

Most Recent Stories

More News
MoonLake's Third Consecutive Quarter Without Revenue Before the BLA Decision

Barchart Research What to Expect from MLTX Earnings MLTX Generated May 8, 2026 Current Price $17.06 EPS Estimate $$-0.91 Consensus Rating Moderate Buy Average Move 3.00% MoonLake's Third Consecutive Quarter...

MLTX : 17.90 (-4.38%)
MoonLake's Third Consecutive Quarter Without Revenue Before the BLA Decision

Barchart Research What to Expect from MLTX Earnings MLTX Generated May 8, 2026 Current Price $17.06 EPS Estimate $$-0.91 Consensus Rating Moderate Buy Average Move 3.00% MoonLake's Third Consecutive Quarter...

MLTX : 17.90 (-4.38%)
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer

Brings 20+ years of clinical development experience in autoimmune and inflammatory diseases, including OX40/OX40L program leadership Will build and lead Imagene’s clinical organization and drive...

MLTX : 17.90 (-4.38%)
IMA : 5.65 (-0.70%)
BioTech Breakout: MoonLake Up 30% On FDA Wins

MoonLake shares are rallying after the FDA granted Fast Track designation for its lead drug and cleared the path for a major filing later this year.

MLTX : 17.90 (-4.38%)
Stocks Boosted by Chip Demand Optimism

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.60%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.32%. March E-mini...

MSTR : 120.44 (-6.90%)
BLK : 995.60 (-2.64%)
AMAT : 453.01 (-9.71%)
MPC : 262.01 (-1.89%)
SNDK : 1,559.32 (-11.39%)
ADI : 401.39 (-6.38%)
MLTX : 17.90 (-4.38%)
$IUXX : 28,957.60 (-4.77%)
COIN : 152.40 (-7.15%)
ASML : 1,641.74 (-6.59%)
ZNU26 : 109-025s (-0.47%)
OXY : 56.93 (-2.97%)
Stocks Supported by Strength in Chip Makers and US Economic News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.07%. March E-mini S&P futures (ESH26...

BLK : 995.60 (-2.64%)
MSTR : 120.44 (-6.90%)
AMAT : 453.01 (-9.71%)
MPC : 262.01 (-1.89%)
SNDK : 1,559.32 (-11.39%)
ADI : 401.39 (-6.38%)
MLTX : 17.90 (-4.38%)
$IUXX : 28,957.60 (-4.77%)
ASML : 1,641.74 (-6.59%)
ZNU26 : 109-025s (-0.47%)
OXY : 56.93 (-2.97%)
ESM26 : 7,400.50s (-2.64%)
Stock Indexes Rally on Chip Demand Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up +0.55%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.00%. March E-mini S&P futures (ESH26...

BLK : 995.60 (-2.64%)
MSTR : 120.44 (-6.90%)
AMAT : 453.01 (-9.71%)
MPC : 262.01 (-1.89%)
AVGO : 385.73 (-7.92%)
SNDK : 1,559.32 (-11.39%)
MLTX : 17.90 (-4.38%)
$IUXX : 28,957.60 (-4.77%)
ZNU26 : 109-025s (-0.47%)
OXY : 56.93 (-2.97%)
ESM26 : 7,400.50s (-2.64%)
FANG : 192.62 (-5.09%)
MLTX DEADLINE ALERT: Hagens Berman Alerts MoonLake (MLTX) Investors to Today's Lead Plaintiff Deadline in Securities Class Action

SAN FRANCISCO , Dec. 15, 2025 /PRNewswire/ -- Global plaintiffs' rights firm Hagens Berman reminds investors that the Lead Plaintiff Deadline in the securities class action lawsuit against ...

MLTX : 17.90 (-4.38%)
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MLTX

The DJS Law Group reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX ) for violations of §§10(b)...

MLTX : 17.90 (-4.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

MoonLake Immunotherapeutics AG is a clinical-stage biotechnology company. It focused on creating next-level therapies for inflammatory skin and joint diseases. MoonLake Immunotherapeutics AG, formerly known as Helix Acquisition Corp., is based in BOSTON.

See More

Key Turning Points

3rd Resistance Point 19.62
2nd Resistance Point 19.18
1st Resistance Point 18.54
Last Price 17.90
1st Support Level 17.46
2nd Support Level 17.02
3rd Support Level 16.38

See More

52-Week High 62.75
Fibonacci 61.8% 41.05
Fibonacci 50% 34.35
Fibonacci 38.2% 27.65
Last Price 17.90
52-Week Low 5.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.